MB

MPM BioImpact Portfolio holdings

AUM $874M
1-Year Est. Return 79.23%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+79.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$874M
AUM Growth
+$263M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1 +$53.3M
2 +$45.7M
3 +$34.2M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$21.6M
5
URGN icon
UroGen Pharma
URGN
+$17.5M

Top Sells

1 +$33.1M
2 +$25.3M
3 +$17.8M
4
ALKS icon
Alkermes
ALKS
+$16.5M
5
VERA icon
Vera Therapeutics
VERA
+$16.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTX icon
26
Context Therapeutics
CNTX
$207M
$15.7M 1.8%
10,679,391
-4,026,491
ARQT icon
27
Arcutis Biotherapeutics
ARQT
$3.3B
$15.4M 1.77%
+531,200
VTYX icon
28
Ventyx Biosciences
VTYX
$1B
$14.8M 1.69%
+1,639,061
ORIC icon
29
Oric Pharmaceuticals
ORIC
$1.31B
$14.7M 1.68%
1,798,717
+69,339
BLTE
30
Belite Bio
BLTE
$7.14B
$14M 1.61%
+87,760
RAPT icon
31
RAPT Therapeutics
RAPT
$1.68B
$13.5M 1.54%
+397,906
CLYM
32
Climb Bio
CLYM
$488M
$10.7M 1.22%
+2,671,480
ABVX
33
Abivax
ABVX
$9.59B
$7.59M 0.87%
+56,316
RCKT icon
34
Rocket Pharmaceuticals
RCKT
$542M
$5.57M 0.64%
1,586,076
-2,317,305
MAZE
35
Maze Therapeutics
MAZE
$2.19B
$3.36M 0.38%
+81,145
EVMN
36
Evommune Inc
EVMN
$820M
$1.93M 0.22%
+113,022
SRPT icon
37
Sarepta Therapeutics
SRPT
$1.76B
$1.51M 0.17%
70,000
-630,000
HOWL icon
38
Werewolf Therapeutics
HOWL
$29.1M
$884K 0.1%
1,393,557
-1,015,253
AKBA icon
39
Akebia Therapeutics
AKBA
$348M
-2,889,125
ALKS icon
40
Alkermes
ALKS
$4.97B
-549,262
ASMB icon
41
Assembly Biosciences
ASMB
$472M
-39,665
CMPX icon
42
Compass Therapeutics
CMPX
$1B
-5,075,970
DSGN icon
43
Design Therapeutics
DSGN
$595M
-555,187
JANX icon
44
Janux Therapeutics
JANX
$819M
-614,282
RARE icon
45
Ultragenyx Pharmaceutical
RARE
$2.26B
-395,700
RNAM
46
Avidity Biosciences
RNAM
$11.2B
-760,022
RNAC icon
47
Cartesian Therapeutics
RNAC
$197M
-380,000
RPTX
48
DELISTED
Repare Therapeutics
RPTX
-819,924
SLDB icon
49
Solid Biosciences
SLDB
$484M
-1,634,569
SLNO icon
50
Soleno Therapeutics
SLNO
$2.1B
-150,000